On the gene expression landscape of cancer

por Gonzalez, Augusto, Leon, Dario A., Perera, Yasser, Perez, Rolando
Publicado 2023

Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination

por Lobaina, Yadira, Urquiza, Dioslaida, Garay, Hilda, Perera, Yasser, Yang, Ke
Publicado 2021

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor

por Martins, Leila R., Perera, Yasser, Lúcio, Paulo, Silva, Maria G., Perea, Silvio E., Barata, João T.
Publicado 2013

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support

por Perera, Yasser, Melão, Alice, Ramón, Ailyn C., Vázquez, Dania, Ribeiro, Daniel, Perea, Silvio E., Barata, João T.
Publicado 2020

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells

por Ramón, Ailyn C., Basukala, Om, Massimi, Paola, Thomas, Miranda, Perera, Yasser, Banks, Lawrence., Perea, Silvio E.
Publicado 2022

Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines

por Vázquez-Blomquist, Dania, Ramón, Ailyn C., Rosales, Mauro, Pérez, George V., Rosales, Ailenis, Palenzuela, Daniel, Perera, Yasser, Perea, Silvio E.
Publicado 2023

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

por Gottardo, Maria F., Capobianco, Carla S., Sidabra, Johanna E., Garona, Juan, Perera, Yasser, Perea, Silvio E., Alonso, Daniel F., Farina, Hernan G.
Publicado 2020

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition

por Rosales, Mauro, Rodríguez-Ulloa, Arielis, Pérez, George V., Besada, Vladimir, Soto, Thalia, Ramos, Yassel, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

por Rosales, Mauro, Rodríguez-Ulloa, Arielis, Besada, Vladimir, Ramón, Ailyn C., Pérez, George V., Ramos, Yassel, Guirola, Osmany, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Perera, Yasser, Perea, Silvio E.
Publicado 2021

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

por Ramón, Ailyn C., Pérez, George V., Caballero, Evelin, Rosales, Mauro, Aguilar, Daylén, Vázquez-Blomquist, Dania, Ramos, Yassel, Rodríguez-Ulloa, Arielis, Falcón, Viviana, Rodríguez-Moltó, María Pilar, Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

por Pérez, George V., Rosales, Mauro, Ramón, Ailyn C., Rodríguez-Ulloa, Arielis, Besada, Vladimir, González, Luis J., Aguilar, Daylen, Vázquez-Blomquist, Dania, Falcón, Viviana, Caballero, Evelin, Carvalho, Paulo C., Caldeira, Rodrigo Soares, Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

por Rosales, Mauro, Pérez, George V., Ramón, Ailyn C., Cruz, Yiliam, Rodríguez-Ulloa, Arielis, Besada, Vladimir, Ramos, Yassel, Vázquez-Blomquist, Dania, Caballero, Evelin, Aguilar, Daylen, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2021

Positive effects of Phycocyanobilin on gene expression in glutamate-induced excitotoxicity in SH-SY5Y cells and animal models of multiple sclerosis and cerebral ischemia

por Gardón, Daniel Palenzuela, Cervantes-Llanos, Majel, Matamoros, Beatriz Piniella, Rodríguez, Hanlet Camacho, Tan, Chan-yuan, Marín –Prida, Javier, Falcón-Cama, Viviana, Pavón-Fuentes, Nancy, Lemus, Jessica Gómez, Ruiz, Laura de la Caridad Bakos, Argudin, Tamara Díaz, Donato, Gillian Martínez, Perera, Yasser, Yang, Ke, Pentón-Rol, Giselle
Publicado 2022

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

por Cruz, Leticia R., Baladrón, Idania, Rittoles, Aliusha, Díaz, Pablo A., Valenzuela, Carmen, Santana, Raúl, Vázquez, Maria M., García, Ariadna, Chacón, Deyli, Thompson, Delvin, Perera, Gustavo, González, Ariel, Reyes, Rafael, Torres, Loida, Pérez, Jesus, Valido, Yania, Rodriguez, Ralysmay, Vázquez-Bloomquist, Dania M., Rosales, Mauro, Ramón, Ailyn C., Pérez, George V., Guillén, Gerardo, Muzio, Verena, Perera, Yasser, Perea, Silvio E.
Publicado 2020